MedTrace Logo

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

NCT05495529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2022-08-10

No results posted yet for this study

Summary

This study aims to analyse retrospectively the feasibility, the safety, and the efficiency, of biliary or digestive protection with room air interposition for thermal ablation of central liver tumors with high iatrogenic risk.

Thermal ablation is a mini-invasive and curative treatement of liver tumors. However, it requires to be carefull about surrunding organs, such as digestive structures or central biliary tree, which can be injured if not insulated.

The technique of gas interposition to protect adjacent gut is already known and validated with carbonic gas. Nevertheless, resorption of this gas is very fast, making its use tricky to keep a correct insulation during the whole thermal ablation process.

Room air interposition is easy to use and can offer a slow resorption speed. Furthermore no datas are available concerning the use of room air whatever the organ protected, and the protection of central biliary tree whatever the gas used.

Conditions

  • Radiology, Interventional
  • Liver Neoplasm
  • Carcinoma, Hepatocellular (RENI)
  • Neoplasm Metastasis
  • Ablation Techniques
  • Radiofrequency Ablation
  • Microwaves

Interventions

PROCEDURE

Thermal Ablation

Data collection about complications, succes of the procedure, succes of complete treatement, recurrence, biologic pertubations.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • GARGIULO Manuel · Centre Hospitalier Universitaire de Nice

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2021-12-31
Completion
2022-05-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05495529 on ClinicalTrials.gov